MD Anderson and Phoenix to advance cell and gene therapy tech
The University of Texas MD Anderson Cancer Center in the US and Phoenix SENOLYTIX have announced a worldwide cross-licensing agreement…
All articles by Gullapalli Prasanna
Gullapalli Prasanna
-
-
Hengrui Pharma signs deal with Braveheart Bio for HRS-1893
Hengrui Pharma has agreed with US-based Braveheart Bio, which specialises in cardiovascular diseases, granting it an exclusive licence for its…
-
MRM Health gains $64m for microbiome-based biotherapeutic pipeline
Belgium’s MRM Health has concluded a Series B funding round, raising €55m ($64m) to progress its pipeline of microbiome-based biotherapeutic…
-
Gilead Sciences advances HIV prevention with new US partnership
Gilead Sciences has announced a collaboration with the US State Department and the President’s Emergency Plan for AIDS Relief (PEPFAR)…
-
Avadel secures rights to develop valiloxybate globally
Avadel Pharmaceuticals has signed an exclusive worldwide licensing deal with XWPharma for the development and commercialisation of valiloxybate, to treat…
-
Health Canada approves AbbVie’s Elahere for ovarian cancer
Health Canada has approved AbbVie's antibody-drug conjugate (ADC), Elahere (mirvetuximab soravtansine for injection), to treat adults with certain types of…
-
Quotient Sciences and CPI to expedite RNA therapy development
Drug development and manufacturing accelerator Quotient Sciences has entered a partnership with the UK's Centre for Process Innovation (CPI) to…
-
Amgen to invest $600m in new US science and innovation hub
Amgen is set to invest more than $600m to construct a new centre for science and innovation in its US…
-
China’s NMPA conditionally approves Boehringer’s tablets for NSCLC
China's National Medical Products Administration (NMPA) has granted conditional approval to Boehringer Ingelheim's Hernexeos (zongertinib tablets), for use as a…
-
Santhera and Ikris sign distribution agreement for DMD drug in India
Santhera Pharmaceuticals has signed an exclusive agreement with Ikris Pharma Network to distrubute Agamree (vamorolone) in India, targeting the treatment…